Related Experiment Video
Updated: Jan 17, 2026

05:45
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
14.1K
Navigating Diagnostic Complexity in Hailey-Hailey Disease: A Case Report with Clinical-histopathological Correlation
Parth R Goswami1, Gyanendra Singh2, Varniraj Patel3
1Department of Pathology, All India Institute of Medical Sciences, Rajkot, Gujarat, India.
Prague Medical Report
|September 18, 2025
Summary
Hailey-Hailey disease (HHD), a rare genetic skin disorder, is diagnosed through characteristic skin biopsy findings. Early diagnosis and management of this condition improve patient outcomes.
Area of Science:
- Dermatology
- Genetics
- Pathology
Background:
- Hailey-Hailey disease (HHD), or benign familial pemphigus, is a rare autosomal dominant genodermatosis.
- It stems from mutations in the ATP2C1 gene, disrupting keratinocyte adhesion and calcium homeostasis.
Purpose of the Study:
- To present a case of Hailey-Hailey disease in a 50-year-old male.
- To highlight the diagnostic process, including clinical and histopathological features.
- To discuss management strategies and the importance of accurate diagnosis.
Main Methods:
- Clinical examination of a patient with a ten-year history of recurrent skin lesions.
- Histopathological analysis of a skin biopsy.
- Exclusion of differential diagnoses such as intertrigo and Darier disease.
Main Results:
- Diagnosis of HHD confirmed by characteristic histopathological findings, including epidermal changes and acantholysis resembling a "dilapidated brick wall".
- Patient presented with lesions in the axilla and groin, without systemic comorbidities or family history.
- Management involved immunomodulators and topical antibiotics.
Conclusions:
- Correlating clinical and histopathological findings is crucial for diagnosing HHD and differentiating it from other intertriginous dermatoses.
- Timely diagnosis and individualized management improve outcomes for this chronic condition.
- Understanding ATP2C1 mutations may lead to future targeted therapies.

